Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Communications Biology,
Journal Year:
2024,
Volume and Issue:
7(1)
Published: July 31, 2024
Designing
effective
monoclonal
antibody
(mAb)
therapeutics
faces
a
multi-parameter
optimization
challenge
known
as
"developability",
which
reflects
an
antibody's
ability
to
progress
through
development
stages
based
on
its
physicochemical
properties.
While
natural
antibodies
may
provide
valuable
guidance
for
mAb
selection,
we
lack
comprehensive
understanding
of
developability
parameter
(DP)
plasticity
(redundancy,
predictability,
sensitivity)
and
how
the
DP
landscapes
human-engineered
relate
one
another.
These
gaps
hinder
fundamental
profile
cartography.
To
chart
engineered
landscapes,
computed
40
sequence-
46
structure-based
DPs
over
two
million
native
single-chain
sequences.
We
find
lower
redundancy
among
compared
sequence-based
DPs.
Sequence
sensitivity
single
amino
acid
substitutions
varied
by
region
DP,
structure
values
across
conformational
ensemble
structures.
show
that
sequence
are
more
predictable
than
ones
different
machine-learning
tasks
embeddings,
indicating
constrained
design
space.
Human-engineered
localize
within
antibodies,
suggesting
explore
mere
subspaces
one.
Our
work
quantifies
developability,
providing
resource
therapeutic
design.
Analysis
2
reveals
form
This
large-scale
analysis
allows
quantification
plasticity,
accelerating
drug
Language: Английский
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 30, 2023
Abstract
Designing
effective
monoclonal
antibody
(mAb)
therapeutics
faces
a
multi-parameter
optimization
challenge
known
as
“developability”,
which
reflects
an
antibody’s
ability
to
progress
through
development
stages
based
on
its
physicochemical
properties.
While
natural
antibodies
may
provide
valuable
guidance
for
mAb
selection,
we
lack
comprehensive
understanding
of
developability
parameter
(DP)
plasticity
(redundancy,
predictability,
sensitivity)
and
how
the
DP
landscapes
human-engineered
relate
one
another.
These
gaps
hinder
fundamental
profile
cartography.
To
chart
engineered
landscapes,
computed
40
sequence-
46
structure-based
DPs
over
two
million
native
single-chain
sequences.
We
found
lower
redundancy
among
compared
sequence-based
DPs.
Sequence
sensitivity
single
amino
acid
substitutions
varied
by
region
DP,
structure
values
across
conformational
ensemble
structures.
were
more
predictable
than
ones
different
machine-learning
tasks
embeddings,
indicating
constrained
design
space.
Human-engineered
localized
within
sequence
antibodies,
suggesting
that
explore
mere
subspaces
one.
Our
work
quantifies
developability,
providing
resource
therapeutic
design.
Language: Английский
Probing the Protein–Excipient Interaction in the Orally Delivered Protein by Solid-State Hydrogen–Deuterium Exchange Mass Spectrometry and Molecular Dynamics
Xiao Pan,
No information about this author
Sunidhi Lenka,
No information about this author
Jeff Davis
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 28, 2023
The
oral
administration
of
protein
therapeutics
in
solid
dosage
form
is
gaining
popularity
due
to
its
benefits,
such
as
improved
medication
adherence,
convenience,
and
ease
use
for
patients
compared
traditional
parental
delivery.
However,
formulating
biologics
presents
challenges
related
pH
barriers,
enzymatic
breakdown,
poor
bioavailability.
Therefore,
understanding
the
interaction
between
excipients
state
crucial
formulation
development.
In
this
Letter,
we
present
a
case
study
focused
on
investigating
role
aggregation
during
production
single
variable
domain
heavy
chain
(VHH)
protein.
We
employed
solid-state
hydrogen–deuterium
exchange
coupled
with
mass
spectrometry
(ssHDX-MS)
at
both
intact
peptide
levels
assess
differences
protein–excipient
interactions
two
formulations.
ssHDX-MS
analysis
revealed
that
one
effectively
prevents
compaction
by
blocking
β-sheets
across
VHH
protein,
thereby
preventing
β-sheet−β-sheet
interactions.
Spatial
propensity
(SAP)
mapping
cosolvent
simulation
from
molecular
dynamics
(MD)
further
validated
sites
identified
through
ssHDX-MS.
Additionally,
MD
demonstrated
involves
hydrophilic
and/or
hydrogen
bonding.
This
novel
approach
holds
significant
potential
can
guide
process
development
orally
delivered
forms,
ultimately
enhancing
their
efficacy
stability.
Language: Английский